Ruth M Baxter1, Valerie A Arboleda, Hane Lee, Hayk Barseghyan, Margaret P Adam, Patricia Y Fechner, Renee Bargman, Catherine Keegan, Sharon Travers, Susan Schelley, Louanne Hudgins, Revi P Mathew, Heather J Stalker, Roberto Zori, Ora K Gordon, Leigh Ramos-Platt, Anna Pawlikowska-Haddal, Ascia Eskin, Stanley F Nelson, Emmanuèle Délot, Eric Vilain. 1. Departments of Human Genetics (R.M.B., V.A.A., H.B., A.E., S.F.N., E.D., E.V.) and Pathology and Laboratory Medicine (V.A.A., H.L., S.F.N.), David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095; Department of Pediatrics (M.P.A.), University of Washington, Seattle, Washington 98195; Department of Endocrinology (P.Y.F.), Seattle Children's Hospital, Seattle, Washington 98105; Nassau University Medical Center (R.B.), East Meadow, New York 11554; Departments of Pediatrics and Human Genetics (C.K.), Ann Arbor, Michigan 48109; The Children's Hospital Colorado (S.T.), Aurora, Colorado 80045; Division of Medical Genetics (S.S., L.H.), Stanford University, Lucile Packard Children's Hospital, Stanford, California 94305; TriStar Children's Specialists (R.P.M.), Nashville, Tennessee 37203; Division of Pediatric Genetics and Metabolism (H.J.S., R.Z.), University of Florida, Gainesville, Florida 32610; Cedars-Sinai Medical Center (O.K.G.), Los Angeles, California 90048; Children's Hospital of Los Angeles (L.R.-P.), Los Angeles, California 90027; and Departments of Pediatrics (A.P.-H., E.D., E.V.) and Urology (E.V.), David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095.
Abstract
CONTEXT: Disorders of sex development (DSD) are clinical conditions where there is a discrepancy between the chromosomal sex and the phenotypic (gonadal or genital) sex of an individual. Such conditions can be stressful for patients and their families and have historically been difficult to diagnose, especially at the genetic level. In particular, for cases of 46,XY gonadal dysgenesis, once variants in SRY and NR5A1 have been ruled out, there are few other single gene tests available. OBJECTIVE: We used exome sequencing followed by analysis with a list of all known human DSD-associated genes to investigate the underlying genetic etiology of 46,XY DSD patients who had not previously received a genetic diagnosis. DESIGN: Samples were either submitted to the research laboratory or submitted as clinical samples to the UCLA Clinical Genomic Center. Sequencing data were filtered using a list of genes known to be involved in DSD. RESULTS: We were able to identify a likely genetic diagnosis in more than a third of cases, including 22.5% with a pathogenic finding, an additional 12.5% with likely pathogenic findings, and 15% with variants of unknown clinical significance. CONCLUSIONS: Early identification of the genetic cause of a DSD will in many cases streamline and direct the clinical management of the patient, with more focused endocrine and imaging studies and better-informed surgical decisions. Exome sequencing proved an efficient method toward such a goal in 46,XY DSD patients.
CONTEXT: Disorders of sex development (DSD) are clinical conditions where there is a discrepancy between the chromosomal sex and the phenotypic (gonadal or genital) sex of an individual. Such conditions can be stressful for patients and their families and have historically been difficult to diagnose, especially at the genetic level. In particular, for cases of 46,XY gonadal dysgenesis, once variants in SRY and NR5A1 have been ruled out, there are few other single gene tests available. OBJECTIVE: We used exome sequencing followed by analysis with a list of all known humanDSD-associated genes to investigate the underlying genetic etiology of 46,XY DSDpatients who had not previously received a genetic diagnosis. DESIGN: Samples were either submitted to the research laboratory or submitted as clinical samples to the UCLA Clinical Genomic Center. Sequencing data were filtered using a list of genes known to be involved in DSD. RESULTS: We were able to identify a likely genetic diagnosis in more than a third of cases, including 22.5% with a pathogenic finding, an additional 12.5% with likely pathogenic findings, and 15% with variants of unknown clinical significance. CONCLUSIONS: Early identification of the genetic cause of a DSD will in many cases streamline and direct the clinical management of the patient, with more focused endocrine and imaging studies and better-informed surgical decisions. Exome sequencing proved an efficient method toward such a goal in 46,XY DSDpatients.
Authors: L F M van der Zanden; I A L M van Rooij; W F J Feitz; B Franke; N V A M Knoers; N Roeleveld Journal: Hum Reprod Update Date: 2012-02-26 Impact factor: 15.610
Authors: V A Arboleda; H Lee; F J Sánchez; E C Délot; D E Sandberg; W W Grody; S F Nelson; E Vilain Journal: Clin Genet Date: 2012-05-01 Impact factor: 4.438
Authors: J E H Bergman; N Janssen; L H Hoefsloot; M C J Jongmans; R M W Hofstra; C M A van Ravenswaaij-Arts Journal: J Med Genet Date: 2011-03-04 Impact factor: 6.318
Authors: Ieuan A Hughes; John D Davies; Trevor I Bunch; Vickie Pasterski; Kiki Mastroyannopoulou; Jane MacDougall Journal: Lancet Date: 2012-06-13 Impact factor: 79.321
Authors: Alexander Pearlman; Johnny Loke; Cedric Le Caignec; Stefan White; Lisa Chin; Andrew Friedman; Nicholas Warr; John Willan; David Brauer; Charles Farmer; Eric Brooks; Carole Oddoux; Bridget Riley; Shahin Shajahan; Giovanna Camerino; Tessa Homfray; Andrew H Crosby; Jenny Couper; Albert David; Andy Greenfield; Andrew Sinclair; Harry Ostrer Journal: Am J Hum Genet Date: 2010-12-10 Impact factor: 11.025
Authors: Samuel P Strom; Hane Lee; Kingshuk Das; Eric Vilain; Stanley F Nelson; Wayne W Grody; Joshua L Deignan Journal: Genet Med Date: 2014-01-09 Impact factor: 8.822
Authors: Matthew S Bramble; Ellen H Goldstein; Allen Lipson; Tuck Ngun; Ascia Eskin; Jason E Gosschalk; Lara Roach; Neerja Vashist; Hayk Barseghyan; Eric Lee; Valerie A Arboleda; Daniel Vaiman; Zafer Yuksel; Marc Fellous; Eric Vilain Journal: Hum Reprod Date: 2016-02-23 Impact factor: 6.918
Authors: John C Achermann; Sorahia Domenice; Tania A S S Bachega; Mirian Y Nishi; Berenice B Mendonca Journal: Nat Rev Endocrinol Date: 2015-05-05 Impact factor: 43.330